A buyer cannot approve Capcox-TH tablets from the brand name alone: the exact active-ingredient strengths, regulatory permission, manufacturing site, safety information and batch evidence must match. By the end, you will have a practical checklist for comparing a Punjab manufacturer, supplier or third-party manufacturing proposal before placing an order.
Key takeaways
- Ask for the exact active ingredients and strength per tablet.
- Confirm the dosage form and approved label before ordering.
- Request the batch number, certificate of analysis and pack photographs.
- Check the manufacturer’s licence separately from the Punjab seller’s details.
Verify the composition, dosage form and approved label before ordering
A Capcox-TH quotation is not acceptable until the seller identifies the exact active ingredients and strength per tablet. The name alone does not establish whether the product is the aceclofenac 100 mg, paracetamol 325 mg and thiocolchicoside 4 mg combination, or a different approved composition marketed under a similar name.
1. Request the current product artwork, product permission or approval basis, and a batch-specific Certificate of Analysis. Match the generic names, strength per tablet and approved indication across all three documents.
2. Confirm the dosage form in writing: immediate-release tablet, film-coated tablet or another form. Record tablet appearance, strip configuration, pack size, storage conditions and whether the quotation covers the same presentation as the sample.
3. Inspect the carton and blister for the batch number, manufacturing date, expiry date, manufacturing-licence number, storage instruction, statutory caution statements and complete manufacturer’s address. A marketer’s address does not prove where production occurred.
4. Ask whether manufacture is under the site’s own licence or a loan licence. Obtain the current drug-manufacturing licence covering the relevant tablet dosage form, the Schedule M or GMP compliance document, and the approved product permission.
5. Reconcile the physical sample with the approved label. Do not accept a sample whose composition, strength, dosage form or manufacturer differs from the quotation.
For a search such as capcox th tablets manufacturer in punjab, verify the licensed premises separately from the seller. Mohali is in Punjab; Chandigarh has a separate drug-control administration, so a supplier location does not establish the manufacturing-licence jurisdiction.
Build a safe dispensing and medical-information review
Do not approve prescribing copy until it states the exact active ingredients and strengths from the approved product permission. The reviewer must confirm the adult dose, maximum treatment duration, food instructions and missed-dose advice rather than allowing prescribers to infer them from the brand name.
Check the patient record for:
- Pregnancy, breastfeeding or a woman of childbearing potential who is not using contraception; systemic thiocolchicoside is contraindicated in each situation.
- Seizure history or other seizure risk before dispensing thiocolchicoside.
- Uncontrolled hypertension, cardiovascular disease, heart failure, kidney disease, liver disease, peptic ulcer or previous gastrointestinal bleeding when the formulation contains etoricoxib or another NSAID.
- Allergy to NSAIDs, paracetamol or any listed excipient.
- Concurrent anticoagulants, antiplatelets, corticosteroids, nephrotoxic medicines, hepatotoxic medicines or other drugs that raise seizure risk.
If the approved formula contains aceclofenac and paracetamol, warn against another NSAID and every paracetamol-containing product. The medical-information sheet must state the permitted daily exposure and the consequences of exceeding it, including gastrointestinal injury, kidney injury and liver toxicity. If it contains etoricoxib, include blood-pressure, cardiovascular, renal, hepatic and gastrointestinal warnings, plus pregnancy restrictions.
Provide adverse-effect escalation advice: stop and seek urgent care for breathing difficulty, facial swelling, black stools, vomiting blood, severe rash, jaundice, marked reduction in urine or a seizure. Record the indication, duration, counselling and any complaint or suspected adverse event for traceability.
Demand batch-specific quality and pack evidence
A matching commercial batch needs more than a brand name and a supplier’s promise. Match the batch number, manufacturing date, expiry date, approved composition, tablet strength, dosage form and label against the product permission and Certificate of Analysis.
For capcox th tablets third party manufacturing, request these records from the licensed site:
- Current drug-manufacturing licence covering the relevant tablet dosage form and premises
- GMP or Schedule M compliance evidence
- Product permission or approval basis for the exact fixed-dose combination
- Approved artwork, master manufacturing record and executed batch manufacturing record
- Batch-specific Certificate of Analysis, signed by the authorised quality unit
| Document or test | What it proves | What should trigger a query |
|---|---|---|
| Product identity and assay | Each active ingredient is present at the approved strength | Missing individual assay results or unexplained strength limits |
| Uniformity of dosage units and dissolution | Tablets deliver a consistent dose and release correctly | Results reported only as “passed” without method or specification |
| Related substances, degradation products and microbial limits | The batch remains within impurity and microbiological limits | A report covering a different batch or product |
| Stability and pack-integrity data | The tablets remain protected in the proposed blister and foil pack | Data from another pack material, strength or configuration |
Ask for the exact approved composition rather than relying on the Capcox-TH name; brand names do not establish the active ingredients or strengths. Compare the CoA with the approved specification, not merely with an internal supplier standard.
Check that the batch documents identify the licence holder, manufacturing premises and release authority. For loan-licence production, the permission and contract must identify those roles separately. Retain an independently collected sample and photographs of the batch number, seal, strip and carton for later complaint investigation.
Separate the licensed manufacturer from the seller in Punjab
A quotation does not prove who made the tablets. Treat “capcox th tablets supplier mohali” and “capcox th pharmaceutical manufacturer chandigarh” as search labels, not evidence: Mohali is in Punjab, while Chandigarh has a separate drug-control administration. Match the physical plant and licence jurisdiction separately.
- Licensed manufacturer: the company named on the manufacturing licence, product permission, Certificate of Analysis and batch-release record, with the same site address printed on the carton.
- Marketer: the brand-owning or selling company; its address alone does not establish manufacturing.
- Distributor: the wholesaler supplying stock from an invoiced source; it does not manufacture or release the batch.
- Loan-licence holder: the applicant authorised under the Drugs and Cosmetics Rules to use another licensee’s premises. Obtain the loan licence, host-site details and agreement defining release responsibility.
- Procurement agent: an intermediary buying on your instructions. It should not present a purchase invoice as proof of manufacturing authority.
Ask every proposed capcox th tablets supplier mohali for the current drug-manufacturing licence covering tablets, Schedule M or GMP compliance evidence, product permission, site address and batch records. Check the carton for the actual manufacturer’s name and address, licence number, batch number, manufacturing and expiry dates, storage instructions and statutory cautions.
If you are assessing Signoret Pharmaceuticals Private Limited, apply this same test: identify whether its role in your quotation is manufacturer, marketer or contractor, then reconcile that role with the licence, artwork and batch-specific documents. Never approve a Capcox-TH supply on a marketer’s address alone.
Related product
 | Capcox-TH Tablets Capcox-TH is a powerful combination of Etoricoxib and Thiocolchicoside, designed to provide fast and effective relief from muscular pain, spasms,... View product → |
Set contract controls before approving the first commercial batch
Do not approve the first commercial batch until the agreement assigns every release decision to a named party. For capcox th tablets third party manufacturing, identify whether production uses the manufacturer’s own drug licence or a loan licence, then record the licence holder, approved premises, physical manufacturing address and batch-release authority.
| Control point | Contract must define | Release consequence |
|---|---|---|
| Licence and site | Licence type, number, holder, premises and jurisdiction | Reject documents that name only a marketer or procurement agent |
| Product master file | Approved master manufacturing record, specifications and exact commercial pack | No production after an uncontrolled formula, blister, foil or artwork change |
| Quality events | Deviation, out-of-specification and stability investigation owners | Quarantine the batch until written disposition |
| Safety and traceability | Reference-sample retention, complaints, adverse-event reporting and pharmacovigilance timelines | Hold distribution until records and reports are complete |
Use this release sequence:
- The authorised quality unit approves the master manufacturing record, packaging artwork, testing specifications and exact blister configuration before manufacture.
- The manufacturer submits the executed batch record, certificate of analysis, in-process results, finished-product results and line-clearance record.
- The buyer verifies batch number, manufacturing and expiry dates, licence details, storage wording and the actual manufacturer’s address against the approved artwork.
- Release occurs only after review of deviations, OOS results, complaints, reference-sample location and stability evidence for that strength and pack.
Require written change control, audit access, recall allocation and record-retention periods. A purchase order cannot replace these controls.
Frequently asked questions
What must you verify before ordering Capcox-TH tablets?
Request the exact active ingredients, strength per tablet, dosage form and approved label. Do not rely on the Capcox-TH name alone because similar brand names can represent different approved compositions.
What records should a Capcox-TH supplier provide for a batch?
Ask for the batch number, manufacturing and expiry dates, certificate of analysis, pack photographs and evidence linking the batch to the licensed manufacturer.
How do you distinguish a licensed manufacturer from a seller in Punjab?
Check the manufacturer’s name and address, manufacturing licence details and role in the supply chain separately from the seller’s GST, office and contact details. A Punjab seller is not automatically the product manufacturer.
What contract controls should be agreed before the first commercial batch?
Define the approved composition and artwork, testing requirements, release documents, change-notification process, complaint handling, recall responsibilities and acceptance criteria for the first commercial batch.
Keywords
